Literature DB >> 32171886

NEDD4 E3 ligase: Functions and mechanism in human cancer.

Zhi-Wei Wang1, Xiaoli Hu2, Miaomiao Ye2, Min Lin2, Man Chu3, Xian Shen4.   

Abstract

A growing amount of evidence indicates that the neuronally expressed developmentally downregulated 4 (NEDD4, also known as NEDD4-1) E3 ligase plays a critical role in a variety of cellular processes via the ubiquitination-mediated degradation of multiple substrates. The abnormal regulation of NEDD4 protein has been implicated in cancer development and progression. In this review article, we briefly delineate the downstream substrates and upstream regulators of NEDD4, which are involved in carcinogenesis. Moreover, we succinctly elucidate the functions of NEDD4 protein in tumorigenesis and progression, including cell proliferation, apoptosis, cell cycle, migration, invasion, epithelial mesenchymal transition (EMT), cancer stem cells, and drug resistance. The findings regarding NEDD4 functions are further supported by knockout mouse models and human tumor tissue studies. This review could provide a promising and optimum anticancer therapeutic strategy via targeting the NEDD4 protein.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer; E3 ligases; NEDD4; Therapy; Ubiquitination

Year:  2020        PMID: 32171886     DOI: 10.1016/j.semcancer.2020.03.006

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  15 in total

1.  Lower expression of PDZRN3 induces endometrial carcinoma progression via the activation of canonical Wnt signaling.

Authors:  Qiuhong Li; Jie Zhong; Shangjie Yang; Yanping Liang
Journal:  Oncol Lett       Date:  2022-01-27       Impact factor: 2.967

Review 2.  The roles of E3 ligases in Hepatocellular carcinoma.

Authors:  Zongdong Yu; Hong Li; Jie Zhu; Haibiao Wang; Xiaofeng Jin
Journal:  Am J Cancer Res       Date:  2022-03-15       Impact factor: 6.166

3.  Down-regulated NEDD4L facilitates tumor progression through activating Notch signaling in lung adenocarcinoma.

Authors:  Liping Lin; Xuan Wu; Yuanxue Jiang; Caijiu Deng; Xi Luo; Jianjun Han; Jiazhu Hu; Xiaolong Cao
Journal:  PeerJ       Date:  2022-05-24       Impact factor: 3.061

4.  NEDD4 triggers FOXA1 ubiquitination and promotes colon cancer progression under microRNA-340-5p suppression and ATF1 upregulation.

Authors:  Meng Yue; Zhennan Yun; Shiquan Li; Guoqiang Yan; Zhenhua Kang
Journal:  RNA Biol       Date:  2021-02-11       Impact factor: 4.652

5.  Development and characterisation of SMURF2-targeting modifiers.

Authors:  Dhanoop Manikoth Ayyathan; Gal Levy-Cohen; Moran Shubely; Sandy Boutros-Suleiman; Veronica Lepechkin-Zilbermintz; Michael Shokhen; Amnon Albeck; Arie Gruzman; Michael Blank
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

6.  Nitidine chloride suppresses NEDD4 expression in lung cancer cells.

Authors:  Jing Zhang; Ruoxue Cao; Chaoqun Lian; Tong Cao; Ying Shi; Jia Ma; Peter Wang; Jun Xia
Journal:  Aging (Albany NY)       Date:  2020-12-03       Impact factor: 5.682

7.  Beraprost ameliorates postmenopausal osteoporosis by regulating Nedd4-induced Runx2 ubiquitination.

Authors:  Huo-Liang Zheng; Wen-Ning Xu; Wen-Sheng Zhou; Run-Ze Yang; Peng-Bo Chen; Tao Liu; Lei-Sheng Jiang; Sheng-Dan Jiang
Journal:  Cell Death Dis       Date:  2021-05-15       Impact factor: 8.469

8.  NEDD9 overexpression: Prognostic and guidance value in acute myeloid leukaemia.

Authors:  Shenghao Hua; Tao Feng; Lei Yin; Qi Wang; Xuejun Shao
Journal:  J Cell Mol Med       Date:  2021-08-25       Impact factor: 5.310

Review 9.  Diverse Roles of F-BoxProtein3 in Regulation of Various Cellular Functions.

Authors:  Zhiyang Zhang; Zhengqi Bao; Penglian Gao; Junyi Yao; Peter Wang; Damin Chai
Journal:  Front Cell Dev Biol       Date:  2022-01-19

Review 10.  The emerging role of WWP1 in cancer development and progression.

Authors:  Xiaoli Hu; Jiangtao Yu; Zixia Lin; Renqian Feng; Zhi-Wei Wang; Gang Chen
Journal:  Cell Death Discov       Date:  2021-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.